Profile
ABVX VRTX REGN VRNA ARGX ALNY
Company Name Abivax S.A. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $9.49B $116.75B $76.56B $72.68B $52.08B $51.68B
Employees 0.07K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Marc de Garidel Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ABVX VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ABVX VRTX REGN VRNA ARGX ALNY
Last Close $113.62 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $113.68 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $5.24 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -0.05 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 2068.32 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ABVX VRTX REGN VRNA ARGX ALNY
1 Month Return 22.53 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 62.29 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 1790.52 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 1436.44 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 1452.19 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 1175.2 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVX VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -293.27 % 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Growth
ABVX VRTX REGN VRNA ARGX ALNY
Asset Growth -37.25 % 14.15 % 53.91 %
Gross Profit Growth 135.94 % 12.5 % -
Revenue Growth 133.54 % 8.27 % -
Revenue 3 Year 7050.56 % -13.44 % -15.89 %
Revenue 5 Year 104155.36 % 119.18 % -
Revenue 10 Year 11236.53 % 429.43 % -
EBIT Growth -29.17 % 13.17 % -131.37 %
Net Income Growth -19.29 % 11.61 % -224.78 %
Net Income 3 Yeari Growth Per Share -1.78 % -46.47 % -148.34 %
Net Income 5 Yeari Growth Per Share -11.16 % 111.07 % 25.82 %
Net Income 10 Yeari Growth Per Share -410.21 % 1232.49 % -35.51 %
Operating Income Growth -35.81 % -8.23 % -133.02 %
Operating Cash Flow Growth (CFG) -54.06 % -3.78 % -143.33 %
Operating 3 Year CFG 17.27 % -38.85 % -170.73 %
Operating 5 Year CFG -8.35 % 84.11 % 54.81 %
Operating 10 Year CFG -585.58 % 517.51 % 40.15 %
EPS Growth 18.37 % 10.39 % -214.81 %
EPS Diluted Growth 18.37 % 10.27 % -208.93 %
Book Value Per Share -85.86 % 11.76 % -22.82 %
Share Holder 3 Year Equity Growth Per Share -61.63 % 53.21 % 1.82 %
Share Holder 5 Year Equity Growth Per Share -57.82 % 167.88 % -24.45 %
Share Holder 10 Year Equity Growth Per Share -82.41 % 1113.59 % -71.86 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 67.74 % 0.06 % 139.05 %
Free Cash Flow Growth -54.29 % -0.08 % -144.48 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ABVX VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 100 % 86.28 % 85.39 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -163.31 % 14.78 % 11.4 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 5077.65 % 19.62 % 15.31 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -2731.94 % 19.59 % 10.32 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 98 % 82.61 % 88.98 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 100.12 % 111.4 % 139.5 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -3306.18 % 34.06 % 25.89 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -138.75 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.51 1.93 1.91 3.33
Payables Turnover TTM 0.01 0.4 2.3 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.64 0.94 2.26 6.82
Fixed Asset Turnover TTM 278.97 % 388.59 % 284.82 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 5.03 % 47.15 % 35.47 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -2.16 14.55 48.94 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -2.17 13.06 40.09 -0.85 5.58 1.68
Cash Per Share TTM 96.11 % 2459.7 % 8148.65 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -2273.9 % 31.71 % 35.59 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.34 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -138.75 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -61.36 34.99 18.43 -995.27 133.11 233.46
Price To Operating Cash Flows Ratio TTM -50.1 31.28 15.15 -126.33 152.03 193.4
Price Cash Flow Ratio TTM -50.1 31.28 15.15 -126.33 152.03 193.4
Income Statement (TTM)
ABVX VRTX REGN VRNA ARGX ALNY
Revenue $0.01B $11.02B $14.2B $0.03B $2.19B $2.25B
Gross Profit $0.01B $9.49B $12.23B $0.03B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 86.13% 93.89% 89.62% 85.62%
EBITDA $-0.17B $0.49B $5.32B $-0.12B $0.11B $-0.18B
Net Income $-0.18B $-0.54B $4.41B $-0.14B $0.83B $-0.28B
EPS Diluted -2.8 -2.08 38.34 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ABVX VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.05B $1.66B $2.7B $0.12B $0.03B $2.59B
Total Liabilities $0.16B $6.12B $8.41B $0.27B $0.7B $4.17B
Total Equity $0.04B $16.41B $29.35B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $0.02B $1.93B $1.73B
Total Debt $0.1B $1.75B $2.7B $0.12B $0.04B $2.74B
Total Assets $0.21B $22.53B $37.76B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ABVX VRTX REGN VRNA ARGX ALNY
Net Income $-0.18B $-0.54B $4.41B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.15B $-0.49B $4.42B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 28.72
AARD Aardvark Therapeutics, Inc. Common Stock 13.575
ABCL AbCellera Biologics Inc. 3.465
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.92
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.105
ABPWW 0.014
ABSI Absci Corporation 3.55
ABUS Arbutus Biopharma Corporation 4.58
ABVC ABVC BioPharma, Inc. 2.045
ACAD ACADIA Pharmaceuticals Inc. 27.177
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4812
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.33
ACIU AC Immune SA 3.0932
ACLX Arcellx, Inc. 65.4
ETFs With Exposure to ABVX
Ticker ETF Name Weight Percentage Price
AADR AdvisorShares Dorsey Wright ADR ETF 3.01 84.8494
DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF 0 54.9899
BOUT Innovator IBD Breakout Opportunities ETF 2.56 36.115
SPEU SPDR Portfolio Europe ETF 0.001349 51.67
BMED BlackRock Future Health ETF 0.09714 30.145
MMSC First Trust Multi-Manager Small Cap Opportunities ETF 0.000001 23.71
PINK Simplify Health Care ETF 2.1507 36.835
DBXW.DE Xtrackers MSCI World Swap UCITS ETF 0.928604 117.155
XWEH.F Xtrackers MSCI World Swap UCITS ETF 0.928604 32.014
XWD1.F Xtrackers MSCI World Swap UCITS ETF 0.928604 16.5615
SXRJ.DE iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0665 325.95
XMWD.L Xtrackers MSCI World Swap UCITS ETF 0.928604 138.79
CES1.L iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0539 28587.8
LU2263803533.SG Xtrackers MSCI World Swap UCITS 0.842973 22.77
XWEH.DE Xtrackers MSCI World Swap UCITS ETF 0.928604 46.97
XWD1.SG Xtrackers MSCI World Swap UCITS 0.928604 22.605
Unlock